Reliance Jio Vs Airtel: Prepaid Recharge Plan Priced At Rs 449 Compared
Sunil Mittal-owned Bharti Airtel has recently launched a prepaid plan priced at Rs 449 to take on Reliance Jio's plan of the same amount. Since the launch of Mukesh Ambani-owned Reliance Jio in September 2016, the telecom sector in country has seen a data war -- as data packs are the most popular among customers -- which has forced other telcos (telecom comapnies) to offer data and voice call packs at lower rates to lure and retain customers.Â
Airtel's Rs 449 recharge pack in detail:
Airtel's Rs. 449 prepaid recharge plan offers 2 GB of 3G/4G data per day, according to the telecom operator's website. The pack is valid for a period of 70 days which adds up to a total of 140 GBs of data. The pack also offers unlimited local, STD and roaming voice calls along with 100 local and STD SMSes.Â
Reliance Jio's Rs 449 recharge pack in detail:
Reliance Jio's Rs 449 recharge pack offers 1.5 GB of 4G data per day post which the speed gets reduced to 64 Kbps. However, this pack is valid for a period of 91 days which adds up to a total of 136 GBs of data. The pack also offers unlimited local, STD and roaming voice calls, 100 local and STD SMSes and complimentary subscription to Jio apps. Â
Reliance Jio and Airtel also offer a prepaid recharge pack priced at Rs 448.
Under the pack, Airtel offers 1.4 GB of 3G/4G data per day for a period of 82 days. The pack also offers unlimited local, STD and roaming voice calls along with 100 local and STD SMSes.Â
For Rs 448, Jio offers 2 GB of 4G data per day post which the speed gets reduced to 64 Kbps which is valid for a period of 84 days. The pack also offers unlimited local, STD and roaming voice calls, 100 local and STD SMSes and complimentary subscription to Jio apps.Â
-
Getting To Work Costs Women More | The Reason Why
It is not just about women paying more than men. It is about women paying much more in cities than in villages.
-
AI Bias In Investing Cannot Be Eliminated, But It Can Be Governed
Framing is a particularly important example as identical financial information presented in terms of gains rather than losses can lead an LLM to reach a different assessment.
-
Joining The Dots | Dark Skies, Steady Diya: Why Hope Holds This Diwali
With war, a weak rupee and foreign outflows weighing on sentiment, policymakers at the NDTV World Summit and market veterans at NDTV Profit Ignite: Diwali Edition offered the same advice: stay invested and filter out the noise.
-
The Curious Case of Equitas Small Finance Bank And A CEO Who Quit For Stock
PN Vasudevan believes persistent investor concerns over a perceived conflict of interest had become a governance overhang on Equitas Small Finance Bank's stock, even as the lender improved profitability and asset quality.
-
Talking Points This Week: AI Cash Burn, A Tiger Comeback And An India That Still Finds Its Own Path
India is not immune to higher oil or tighter global liquidity, yet its earnings base is broader, its domestic policy levers are still available.
-
Foreign Investors Own Half Of HDFC Bank and ICICI Bank. An LTCG Cut Could Matter Most Here
Foreign portfolio investors have US$115 billion parked in HDFC Bank, ICICI Bank. If the government cuts long-term capital gains tax, Jefferies says returning foreign money could land here first.
-
'Never Seen This Level Of Negativity': Sandeep Tandon Says The Next Rally May Be Closer Than You Think
Veteran investor Sandeep Tandon says foreign selling is easing, large-caps are due a comeback and mid-caps are crowded, while he turns positive on gold, power and pharma this Diwali.
-
Indians Stay With Family, Not In Hotels | The Reason Why
India still lacks enough clean, reliable and affordable hotels for budget-conscious travellers.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.
